Ignite Creation Date:
2025-12-25 @ 2:53 AM
Ignite Modification Date:
2025-12-26 @ 1:34 AM
Study NCT ID:
NCT04566133
Status:
TERMINATED
Last Update Posted:
2023-08-21
First Post:
2020-09-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-25
First Submit QC Date:
None
Study First Post Date:
2020-09-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-12
Results First Submit QC Date:
None
Results First Post Date:
2023-08-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-28
Last Update Post Date:
2023-08-21
Last Update Post Date Type:
ACTUAL